Related references
Note: Only part of the references are listed.Discovery and molecular interaction studies of a highly stable, tarantula peptide modulator of acid-sensing ion channel 1
Sing Yan Er et al.
NEUROPHARMACOLOGY (2017)
Gating modifier toxin interactions with ion channels and lipid bilayers: Is the trimolecular complex real?
Akello J. Agwa et al.
NEUROPHARMACOLOGY (2017)
NaV1.7 as a pain target - From gene to pharmacology
Irina Vetter et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitor
M. Flinspach et al.
SCIENTIFIC REPORTS (2017)
Pharmacological characterisation of the highly NaV1.7 selective spider venom peptide Pn3a
Jennifer R. Deuis et al.
SCIENTIFIC REPORTS (2017)
Progress and challenges in the optimization of toxin peptides for development as pain therapeutics
Chawita Netirojjanakul et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2017)
Spider peptide toxin HwTx-IV engineered to bind to lipid membranes has an increased inhibitory potency at human voltage-gated sodium channel hNav1.7
Akello J. Agwa et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2017)
Membrane-binding properties of gating modifier and pore-blocking toxins: Membrane interaction is not a prerequisite for modification of channel gating
Evelyne Deplazes et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2016)
Interaction of Tarantula Venom Peptide ProTx-II with Lipid Membranes Is a Prerequisite for Its Inhibition of Human Voltage-gated Sodium Channel NaV1.7
Sonia Troeira Henriques et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain
Jeremiah D. Osteen et al.
NATURE (2016)
Molecular Interactions between Tarantula Toxins and Low-Voltage-Activated Calcium Channels
Autoosa Salari et al.
SCIENTIFIC REPORTS (2016)
Molecular basis of the interaction between gating modifier spider toxins and the voltage sensor of voltage-gated ion channels
Carus H. Y. Lau et al.
SCIENTIFIC REPORTS (2016)
Seven novel modulators of the analgesic target NaV1.7 uncovered using a high-throughput venom-based discovery approach
Julie K. Klint et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Engineering Potent and Selective Analogues of GpTx-1, a Tarantula Venom Peptide Antagonist of the Na(V)1.7 Sodium Channel
Justin K. Murray et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
The Cystine Knot Is Responsible for the Exceptional Stability of the Insecticidal Spider Toxin ω-Hexatoxin-Hv1a
Volker Herzig et al.
TOXINS (2015)
Design and characterization of novel antimicrobial peptides, R-BP100 and RW-BP100, with activity against Gram-negative and Gram-positive bacteria
Ines M. Torcato et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2013)
Analysis of the Structural and Molecular Basis of Voltage-sensitive Sodium Channel Inhibition by the Spider Toxin Huwentoxin-IV (μ-TRTX-Hh2a)
Natali A. Minassian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Protein backbone and sidechain torsion angles predicted from NMR chemical shifts using artificial neural networks
Yang Shen et al.
JOURNAL OF BIOMOLECULAR NMR (2013)
Isolation of an Orally Active Insecticidal Toxin from the Venom of an Australian Tarantula
Margaret C. Hardy et al.
PLOS ONE (2013)
A positively charged surface patch is important for hainantoxin-IV binding to voltage-gated sodium channels
Yu Liu et al.
JOURNAL OF PEPTIDE SCIENCE (2012)
Voltage-gated sodium channels at 60: structure, function and pathophysiology
William A. Catterall
JOURNAL OF PHYSIOLOGY-LONDON (2012)
Sodium Channels in Normal and Pathological Pain
Sulayman D. Dib-Hajj et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 33 (2010)
Targeting voltage sensors in sodium channels with spider toxins
Frank Bosmans et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Preferential Interactions of Guanidinum Ions with Aromatic Groups over Aliphatic Groups
Philip E. Mason et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Tarantula huwentoxin-IV inhibits neuronal sodium channels by binding to receptor site 4 and trapping the domain II voltage sensor in the closed configuration
Yucheng Xiao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Deconstructing voltage sensor function and pharmacology in sodium channels
Frank Bosmans et al.
NATURE (2008)
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
Ian W. Davis et al.
NUCLEIC ACIDS RESEARCH (2007)
Spider peptide toxins as leads for drug development
Pierre Escoubas et al.
EXPERT OPINION ON DRUG DISCOVERY (2007)
Voltage-gated ion channels and gating modifier toxins
William A. Catterall et al.
TOXICON (2007)
Four novel tarantula toxins as selective modulators of voltage-gated sodium channel subtypes
F Bosmans et al.
MOLECULAR PHARMACOLOGY (2006)
Voltage-sensor activation with a tarantula toxin as cargo
LR Phillips et al.
NATURE (2005)
The CCPN data model for NMR spectroscopy: Development of a software pipeline
WF Vranken et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2005)
RECOORD:: A recalculated coordinate database of 500+proteins from the PDB using restraints from the BioMagResBank
AJ Nederveen et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2005)
Solution structure and functional characterization of SGTxl, a modifier of Kv2.1 channel gating
CW Lee et al.
BIOCHEMISTRY (2004)
Structure-activity relationships of hainantoxin-IV and structure determination of active and inactive sodium channel Blockers
DL Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A membrane-access mechanism of ion channel inhibition by voltage sensor toxins from spider venom
SY Lee et al.
NATURE (2004)
Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: The importance of the cyclic cystine knot
ML Colgrave et al.
BIOCHEMISTRY (2004)
The denaturation of circular enterocin AS-48 by urea and guanidinium hydrochloride
ES Cobos et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2002)
The solution structure of gomesin, an antimicrobial cysteine-rich peptide from the spider
N Mandard et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
The cystine knot motif in toxins and implications for drug design
DJ Craik et al.
TOXICON (2001)
Share Paper
